Jessica Donington to Prognosis
This is a "connection" page, showing publications Jessica Donington has written about Prognosis.
Connection Strength
0.532
-
Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1629-1630.
Score: 0.096
-
Invited commentary. Ann Thorac Surg. 2011 Jul; 92(1):250.
Score: 0.058
-
Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2011; 23(2):137-45.
Score: 0.056
-
Sublobar resection: a movement from the Lung Cancer Study Group. J Thorac Oncol. 2010 Oct; 5(10):1583-93.
Score: 0.055
-
Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
Score: 0.052
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.029
-
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer. J Thorac Oncol. 2020 03; 15(3):344-359.
Score: 0.026
-
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol. 2016 05; 11(5):666-680.
Score: 0.020
-
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol. 2016 05; 11(5):639-650.
Score: 0.020
-
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 05; 11(5):681-692.
Score: 0.020
-
The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 05; 11(5):651-665.
Score: 0.020
-
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.
Score: 0.020
-
Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit? Am Soc Clin Oncol Educ Book. 2016; 35:e460-7.
Score: 0.020
-
Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior. J Thorac Oncol. 2013 Sep; 8(9):1203-11.
Score: 0.017
-
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
Score: 0.013
-
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
Score: 0.010